ENTX

Entera Bio (ENTX)

About Entera Bio (ENTX)

Entera Bio Ltd. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of orally delivered large molecule therapeutics. It s pipeline include PTH(1-34), GLP-1 and GLP-2. The company was founded on September 30, 2009 and is headquartered in Jerusalem, Israel.

Details

Daily high

$1.15

Daily low

$1.11

Price at open

$1.13

52 Week High

$3.22

52 Week Low

$0.91

Market cap

52.2M

Dividend yield

0.00%

Volume

31,094

Avg. volume

198,558

P/E ratio

-4.49

Entera Bio News